Paper Details

  1. Home
  2. Paper Details

Dermoscopic monitoring of efficacy of ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas.

Author: BavettaMauro, BianchiLuca, CampioneElena, Di PreteMonia, DiluvioLaura, OrlandiAugusto

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This case report examines the use of topical ingenol mebutate gel for the treatment of superficial basal cell carcinoma (BCC). The authors report successful treatment of both pigmented and non-pigmented BCCs with minimal side effects, highlighting the potential of this non-ablative therapy and the usefulness of dermoscopy in monitoring treatment outcomes.
Paper Details　
Original Abstract of the Article :
Basal cell carcinoma is the most common non-melanoma skin cancer, and its incidence continues to raise. Although surgery can be considered the mainstay of therapy, new current pharmacological options are available and focus on tumor eradication, maximizing cosmetic results, and functional capacity. ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/dth.12438

データ提供：米国国立医学図書館（NLM）

Dermoscopic Monitoring of Ingenol Mebutate in Basal Cell Carcinoma

This study investigates the efficacy of topical ingenol mebutate gel, a derivative of the plant Euphorbia Peplus, in treating pigmented and non-pigmented basal cell carcinoma (BCC). The study used dermoscopic evaluation to monitor the outcome of treatment in four patients with superficial BCC. The study found that ingenol mebutate gel therapy was effective and well-tolerated for pigmented and non-pigmented superficial BCC. The study emphasizes the usefulness of dermoscopy in supporting the clinical diagnosis and excluding the presence of tumor residue or recurrence.

A New Tool for BCC Treatment

This study provides evidence for the effectiveness of ingenol mebutate gel in treating superficial BCC. The use of dermoscopy for monitoring treatment response and excluding tumor residue or recurrence is a valuable addition to the clinical management of BCC.

From the Desert to the Clinic

This study highlights the potential of natural products like ingenol mebutate in treating skin cancers. It’s a reminder that nature can provide valuable resources for human health. This research paves the way for new and more effective treatments for BCC.

Dr.Camel's Conclusion

This study demonstrates the efficacy and safety of topical ingenol mebutate gel in treating superficial BCC. The use of dermoscopy for monitoring treatment response adds a valuable tool to the clinical management of this common skin cancer. This research highlights the potential of natural products like ingenol mebutate in developing new and effective therapies.

Date :
  1. Date Completed 2017-03-27
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

27860083

DOI: Digital Object Identifier

10.1111/dth.12438

Related Literature

Article Analysis
・Side Effects of ingenol mebutate topical
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.